Answers are grounded in this paper and cite their sources.
Findings from this large, pharmacoepidemiologic study suggest that 7 or more intravitreous injections of bevacizumab annually is associated with a higher risk of glaucoma surgery and that 4 to 6 injections per year show a nonstatistically significant rate ratio in the same direction.
No takes yet. Share an insight, caveat, or question.
Eadie et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: